Conference Coverage

Autoimmune-mediated gut dysmotility puts patients at risk for bacterial overgrowth

Publish date: October 4, 2016

 

On Twitter @karioakes

Pages

Recommended Reading

Analysis yields ‘strong evidence’ for benefit of physical activity in NAFLD
MDedge Family Medicine
Investigational HCV drug combo yields high SVR12 rates in compensated cirrhosis
MDedge Family Medicine
Biologics did not up risk of serious infections in IBD
MDedge Family Medicine
Nearly half of patients readmitted after liver transplant
MDedge Family Medicine
CSF2RB mutation, common in Ashkenazim, linked to Crohn’s
MDedge Family Medicine
Anticipate, treat GI issues in scleroderma
MDedge Family Medicine
Targeted HCV patients improve on sofosbuvir/daclatasvir combination
MDedge Family Medicine
Direct-acting antivirals: One of several keys to HCV eradication by 2030
MDedge Family Medicine
Nonalcoholic fatty liver disease estimated to cost $103 billion annually
MDedge Family Medicine
FDA approves biosimilar adalimumab
MDedge Family Medicine